https://www.selleckchem.com/products/g007-lk.html
Older adults with multiple sclerosis (MS) experience mobility impairments, but conventional brain imaging is a poor predictor of walking abilities in this population. To test whether brain metabolites measured with Magnetic Resonance Spectroscopy (MRS) are associated with walking performance in older adults with MS. Fifteen older adults with MS (mean age 60.9, SD 5.1) and 22 age-matched healthy controls (mean age 64.2, SD 5.7) underwent whole-brain MRS and mobility testing. Levels of N-acetylaspartate (NAA), myo-inositol (MI), choline (
إعجاب
علق
شارك
